MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
News|Webinars|January 25, 2022
Optimizing the Payer/Provider Relationship for a Successful Annual Enrollment Period, Part 2
Experts discuss current trends in Medicare Advantage during the current annual enrollment period, best practices for communication, and gain clarity about the benefits and costs for both providers and beneficiaries.
Advertisement
In the latest Matters in Managed Care webinar, experts discussed current trends in Medicare Advantage during the current annual enrollment period, best practices for communication, and gain clarity about the benefits and costs for both providers and beneficiaries. They discussed the health system, provider, and payer perspectives.
Steve Evans, MD, vice president for quality and utilization management, Intermountain Healthcare, moderated the panel with:
- Judith Ford, MD, medical director, Intermountain Healthcare
- Othella Ann Jurani-Suarez, MD, medical director, Intermountain Healthcare
- Kristine Gates, government program sales director, SelectHealth
- Matt Maher, senior sales manager, Humana
- Sherry Stanislaw, general manager, officer, SCAN Health Plan
In segment 2, they discussed trends in Medicare Advantage.
Advertisement
Related to this article
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Sustainable models require asking what a result shows, what design produced it, and whether the design was built to measure value or just produce a number.
CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
Aligning financial incentives with patient-centered care is becoming an increasingly complex path to navigate within oncology.
The 2026 COA Payer Exchange and Innovation Summit began with a panel on AI and the ever-changing digital infrastructure in community oncology.
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion
3
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
4
Who Recommends COVID-19 Vaccines Without ACIP?
5